PPT - Psychopharmacotherapy

Pharmacotherapy of psychic and neurological disorders

The focus of PPT is on pharmaceutical agents in the fields of psychiatry and neurology – starting with their clinical development (Phase III), via their marketing approval, all the way through to their established use.

In synopses, original papers (in particular non-interventional studies), and discussion papers, experts pass on information on the effects, safety-related and health-economical aspects, and the therapeutical relevance of these drugs.

Reports on clinical studies and on conferences provide an overview of the current state of knowledge.


  • Monthly updates